These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 21175849)
1. The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience. Shirakawa H; Ishida H; Shimizu T; Omoto K; Iida S; Toki D; Tanabe K Clin Transplant; 2011; 25(6):878-84. PubMed ID: 21175849 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814 [TBL] [Abstract][Full Text] [Related]
3. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation. Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588 [TBL] [Abstract][Full Text] [Related]
4. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans. Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805 [TBL] [Abstract][Full Text] [Related]
5. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab. Chikaraishi T; Sasaki H; Tsutsumi H; Miyano S; Nakazawa R; Nakano T; Kitajima K; Kudo H; Takahashi T; Sato Y; Kimura K Transplant Proc; 2008 Dec; 40(10):3445-7. PubMed ID: 19100409 [TBL] [Abstract][Full Text] [Related]
6. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience. Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802 [TBL] [Abstract][Full Text] [Related]
8. A novel approach to successful ABO-incompatible high-titer renal transplantation. Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213 [TBL] [Abstract][Full Text] [Related]
9. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation. Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498 [TBL] [Abstract][Full Text] [Related]
10. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Saito K; Nakagawa Y; Suwa M; Kumagai N; Tanikawa T; Nishiyama T; Ueno M; Gejyo F; Nishi S; Takahashi K Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803 [TBL] [Abstract][Full Text] [Related]
11. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810 [TBL] [Abstract][Full Text] [Related]
12. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab. Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955 [TBL] [Abstract][Full Text] [Related]
13. ABO-incompatible renal transplantation at Tokyo Women's Medical University. Tanabe K; Tokumoto T; Ishida H; Toma H; Nakajima I; Fuchinoue S; Teraoka S Clin Transpl; 2003; ():175-81. PubMed ID: 15387109 [TBL] [Abstract][Full Text] [Related]
14. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations. Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215 [TBL] [Abstract][Full Text] [Related]
15. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Tydén G; Kumlien G; Fehrman I Transplantation; 2003 Aug; 76(4):730-1. PubMed ID: 12973118 [TBL] [Abstract][Full Text] [Related]
16. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation. Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M; Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis. Han S; Hwang E; Park S; Park U; Kim H; Cho W Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation. Sugiyama K; Hyodo Y; Aikawa A Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258 [TBL] [Abstract][Full Text] [Related]